Position history for ExodusPoint Capital Management, LP's holdings in ImmunityBio, Inc.
ExodusPoint Capital Management, LP holds 367,881 shares of IBRX (ImmunityBio, Inc.), worth $728,404 as of 2025-Q4. The position was increased (++126.5% shares). IBRX represents 0.0% of ExodusPoint Capital Management, LP's portfolio.
Current Value
$728,404
Current Shares
367,881
Total Value Change
+$728,404
Total Shares Change
+367,881
Other major holders of IBRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 367,881 |
+126.5% |
| $728,404 |
| 0.0% |
| $1.98 |
40 |
| 2025-Q3 | New | 162,383 | - | $399,462 | 0.0% | $2.57 | 33 |
| 2024-Q4 | Exited | 0 | -100.0% | $0 | 0.0% | $2.68 | 0 |
| 2024-Q3 | New | 135,029 | - | $502 | 0.0% | $3.93 | 15 |
| 2024-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $5.37 | 0 |